KPTI
Karyopharm Therapeutics Inc
Price:  
0.86 
USD
Volume:  
170,186.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KPTI Fair Value

-518.66 %
Upside

As of 2024-10-14, the Fair Value of Karyopharm Therapeutics Inc (KPTI) is -3.61 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.86 USD, the upside of Karyopharm Therapeutics Inc is -518.66%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.86 USD
Stock Price
-3.61 USD
Fair Price
FAIR VALUE CALCULATION

KPTI Fair Value

Peter Lynch's formula is:

KPTI Fair Value
= Earnings Growth Rate x TTM EPS
KPTI Fair Value
= 5.00 x -0.72
KPTI Fair Value
= -3.61

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -199.60 -196.30 -124.10 -165.30 -143.10 -165.68
YoY growth -11.88% 1.65% 36.78% -33.20% 13.43% 1.36%

KPTI Fair Value - Key Data

Market Cap (mil) 107.37
P/E
Forward P/E
EPS -0.72
Avg earnings growth rate 1.36%
TTM earnings -89.91